Pitx2 expression promotes p21 expression and cell cycle exit in neural stem cells

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 7, 2012, Pages 884-892

  Heldring, Nina ^a   Joseph, Bertr ^a   Hermanson, Ola ^a   Kioussi, Chrissa ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Chromatin; Neocortex; P21Cip1; P27Kip2; P57Kip2; Pitx; Telencephalon; Transcription

Indexed keywords

NESTIN; PROTEIN P21; TRANSCRIPTION FACTOR PITX2;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; IMMUNOCYTOCHEMISTRY; NEURAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CEREBRAL CORTEX; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; G1 PHASE; HOMEODOMAIN PROTEINS; INTERMEDIATE FILAMENT PROTEINS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; PROMOTER REGIONS, GENETIC; RATS; RECOMBINANT PROTEINS; SCHWANN CELLS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84873105965     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527311201070884     Document Type: Article

References (50)

1. Götz, M.; Huttner, W.B. The cell biology of neurogenesis. Nat. Rev. Mol. Cell Biol., 2005, 6(10), 777-788.
2. Takahashi, T.; Nowakowski, R.S.; Caviness, V.S., Jr. The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall. J. Neurosci., 1995, 15(9), 6046-6057.
3. Calegari, F.; Huttner, W.B. An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. J. Cell Sci., 2003, 116(Pt 24), 4947-4955.
4. Morgan, D.O. Principles of CDK regulation. Nature, 1995, 374(6518), 131-134.
5. Lees, E. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol., 1995, 7(6), 773-780.
6. Marx, J. Cell biology. Cell cycle inhibitors may help brake growth as cells develop. Science, 1995, 267(5200), 963-964.
7. Hunter, T.; Pines, J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell, 1994, 79(4), 573-582.
8. Harper, J.W.; Elledge, S.J.; Keyomarsi, K.; Dynlacht, B.; Tsai, L.H.; Zhang, P.; Dobrowolski, S.; Bai, C.; Connell-Crowley, L.; Swindell, E.; et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 1995, 6(4), 387-400.
9. Matsuoka, S.; Edwards, M.C.; Bai, C.; Parker, S.; Zhang, P.; Baldini, A.; Harper, J.W.; Elledge, S.J. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev., 1995, 9(6), 650-662.
10. Kippin, T.E.; Martens, D.J.; van der Kooy, D. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev., 2005, 19(6), 756-767.
11. Kitamura, K.; Miura, H.; Yanazawa, M.; Miyashita, T.; Kato, K. Expression patterns of Brx1 (Rieg gene), Sonic hedgehog, Nkx2.2, Dlx1 and Arx during zona limitans intrathalamica and embryonic ventral lateral geniculate nuclear formation. Mech. Dev., 1997, 67(1), 83-96.
12. Lindberg, C.; Wunderlich, M.; Ratliff, J.; Dinsmore, J.; Jacoby, D.B. Regulated expression of the homeobox gene, rPtx2, in the developing rat. Dev. Brain Res., 1998, 110(2), 215-226.
13. Muccielli, M.L.; Martinez, S.; Pattyn, A.; Goridis, C.; Brunet, J.F. Otlx2, an Otx-related homeobox gene expressed in the pituitary gland and in a restricted pattern in the forebrain. Mol. Cell. Neurosci., 1996, 8(4), 258-271.
14. Semina, E.V.; Reiter, R.; Leysens, N.J.; Alward, W.L.; Small, K.W.; Datson, N.A.; Siegel-Bartelt, J.; Bierke-Nelson, D.; Bitoun, P.; Zabel, B.U.; Carey, J.C.; Murray, J.C. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat. Genet., 1996, 14(4), 392-399.
15. De Hauwere, R.C.; Leroy, J.G.; Adriaenssens, K.; Van Heule, R. Iris dysplasia, orbital hypertelorism, and psychomotor retardation: a dominantly inherited developmental syndrome. J. Pediatr., 1973, 82(4), 679-681.
16. Summitt, R.L.; Hiatt, R.L.; Duenas, D.; Johnson, W.W. Mesoectodermal dysplasia of the iris and cornea, mental retardation and myopathy: a sporadic case. Birth Defects, 1971, 7(3), 129-135.
17. Gage, P.J.; Suh, H.; Camper, S.A. Dosage requirement of Pitx2 for development of multiple organs. Development, 1999, 126(20), 4643-4651.
18. Kitamura, K.; Miura, H.; Miyagawa-Tomita, S.; Yanazawa, M.; Katoh-Fukui, Y.; Suzuki, R.; Ohuchi, H.; Suehiro, A.; Motegi, Y.; Nakahara, Y.; Kondo, S.; Yokoyama, M. Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra-and periocular mesoderm and right pulmonary isomerism. Development, 1999, 126(24), 5749-5758.
19. Cheng, M.; Olivier, P.; Diehl, J.A.; Fero, M.; Roussel, M.F.; Roberts, J.M.; Sherr, C.J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J., 1999, 18(6), 1571-1583.
20. Martin, D.M.; Skidmore, J.M.; Fox, S.E.; Gage, P.J.; Camper, S.A. Pitx2 distinguishes subtypes of terminally differentiated neurons in the developing mouse neuroepithelium. Dev. Biol., 2002, 252(1), 84-99.
21. Waite, M.R.; Skidmore, J.M.; Billi, A.C.; Martin, J.F.; Martin, D.M. GABAergic and glutamatergic identities of developing midbrain Pitx2 neurons. Dev. Dyn., 2011, 240(2), 333-346.
22. Skidmore, J.M.; Cramer, J.D.; Martin, J.F.; Martin, D.M. Cre fate mapping reveals lineage specific defects in neuronal migration with loss of Pitx2 function in the developing mouse hypothalamus and subthalamic nucleus. Mol. Cell. Neurosci., 2008, 37(4), 696-707.
23. Smidt, M.L.; Potts, K.E.; Tucker, S.P.; Blystone, L.; Stiebel, T.R., Jr.; Stallings, W.C.; McDonald, J.J.; Pillay, D.; Richman, D.D.; Bryant, M.L. A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389A. Antimicrob. Agents Chemother., 1997, 41(3), 515-522.
24. Kioussi, C.; Briata, P.; Baek, S.H.; Rose, D.W.; Hamblet, N.S.; Herman, T.; Ohgi, K.A.; Lin, C.; Gleiberman, A.; Wang, J.; Brault, V.; Ruiz-Lozano, P.; Nguyen, H.D.; Kemler, R.; Glass, C.K.; Wynshaw-Boris, A.; Rosenfeld, M.G. Identification of a Wnt/Dvl/beta-Catenin--> Pitx2 pathway mediating cell-typespecific proliferation during development. Cell, 2002, 111(5), 673-685.
25. Liu, W.; Selever, J.; Lu, M.F.; Martin, J.F. Genetic dissection of Pitx2 in craniofacial development uncovers new functions in branchial arch morphogenesis, late aspects of tooth morphogenesis and cell migration. Development, 2003, 130(25), 6375-6385.
26. Wei, Q.; Adelstein, R.S. Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling. Mol. Biol. Cell, 2002, 13(2), 683-697.
27. Johe, K.K.; Hazel, T.G.; Muller, T.; Dugich-Djordjevic, M.M.; McKay, R.D. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev., 1996, 10(24), 3129-3140.
28. Joseph, B.; Andersson, E.R.; Vlachos, P.; Sodersten, E.; Liu, L.; Teixeira, A.I.; Hermanson, O. p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells. Cell Death Differ., 2009, 16(9), 1256-1265.
29. Castro, D.S.; Hermanson, E.; Joseph, B.; Wallen, A.; Aarnisalo, P.; Heller, A.; Perlmann, T. Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells. J. Biol. Chem., 2001, 276(46), 43277-43284.
30. Hermanson, O.; Jepsen, K.; Rosenfeld, M.G. N-CoR controls differentiation of neural stem cells into astrocytes. Nature, 2002, 419(6910), 934-939.
31. Jepsen, K.; Solum, D.; Zhou, T.; McEvilly, R.J.; Kim, H.J.; Glass, C.K.; Hermanson, O.; Rosenfeld, M.G. SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature, 2007, 450(7168), 415-419.
32. Shih, H.P.; Gross, M.K.; Kioussi, C. Cranial muscle defects of Pitx2 mutants result from specification defects in the first branchial arch. Proc. Natl. Acad. Sci. USA, 2007, 104(14), 5907-5912.
33. Salomoni, P.; Calegari, F. Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. Trends Cell Biol., 2010, 20(5), 233-243.
34. Joseph, B.; Hermanson, O. Molecular control of brain size: regulators of neural stem cell life, death and beyond. Exp. Cell Res., 2010, 316(8), 1415-1421.
35. Amendt, B.A.; Sutherland, L.B.; Semina, E.V.; Russo, A.F. The molecular basis of Rieger syndrome. Analysis of Pitx2 homeodomain protein activities. J. Biol. Chem., 1998, 273(32), 20066-20072.
36. Vadlamudi, U.; Espinoza, H.M.; Ganga, M.; Martin, D.M.; Liu, X.; Engelhardt, J.F.; Amendt, B.A. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J. Cell Sci., 2005, 118(Pt 6), 1129-1137.
37. Wilson, D.S.; Sheng, G.; Jun, S.; Desplan, C. Conservation and diversification in homeodomain-DNA interactions: a comparative genetic analysis. Proc. Natl. Acad. Sci. USA, 1996, 93(14), 6886-6891.
38. Cheng, T.; Rodrigues, N.; Shen, H.; Yang, Y.; Dombkowski, D.; Sykes, M.; Scadden, D.T. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science, 2000, 287(5459), 1804-1808.
39. Li, W.; Sun, G.; Yang, S.; Qu, Q.; Nakashima, K.; Shi, Y. Nuclear receptor TLX regulates cell cycle progression in neural stem cells of the developing brain. Mol. Endocrinol., 2008, 22(1), 56-64.
40. Yamaguchi, T.; Cubizolles, F.; Zhang, Y.; Reichert, N.; Kohler, H.; Seiser, C.; Matthias, P. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev., 2010, 24(5), 455-469.
41. Zhou, Q.; Dalgard, C.L.; Wynder, C.; Doughty, M.L. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells. BMC Neurosci., 2011, 12, 50.
42. Hilton, T.; Gross, M.K.; Kioussi, C. Pitx2-dependent occupancy by histone deacetylases is associated with T-box gene regulation in mammalian abdominal tissue. J. Biol. Chem., 2010, 285(15), 11129-11142.
43. O'Farrell, P.H.; Edgar, B.A.; Lakich, D.; Lehner, C.F. Directing cell division during development. Science, 1989, 246(4930), 635-640.
44. Schneider, J.W.; Gu, W.; Zhu, L.; Mahdavi, V.; Nadal-Ginard, B. Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells. Science, 1994, 264(5164), 1467-1471.
45. Halevy, O.; Novitch, B.G.; Spicer, D.B.; Skapek, S.X.; Rhee, J.; Hannon, G.J.; Beach, D.; Lassar, A.B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science, 1995, 267(5200), 1018-1021.
46. Nguyen, L.; Besson, A.; Heng, J.I.; Schuurmans, C.; Teboul, L.; Parras, C.; Philpott, A.; Roberts, J.M.; Guillemot, F. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev., 2006, 20(11), 1511-1524.
47. Itoh, Y.; Masuyama, N.; Nakayama, K.; Nakayama, K.I.; Gotoh, Y. The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex. J. Biol. Chem., 2007, 282(1), 390-396.
48. Roybon, L.; Hjalt, T.; Christophersen, N.S.; Li, J.Y.; Brundin, P. Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3. J. Neurosci., 2008, 28(14), 3644-3656.
49. Jones, P.A.; Baylin, S.B. The epigenomics of cancer. Cell, 2007, 128(4), 683-692.
50. Wu, X.; Rauch, T.A.; Zhong, X.; Bennett, W.P.; Latif, F.; Krex, D.; Pfeifer, G.P. CpG island hypermethylation in human astrocytomas. Cancer Res., 2010, 70(7), 2718-2727.